1044584-17-9

Basic information

• Product Name: (2S)-N-[(R)-7'-(2-chlorophenyl)-6'-(4-chlorophenyl)-3',4'-dihydrospiro[cyclohexane-1,2'-pyrano[2,3-b]pyridin]-4'-yl]-2-hydroxypropanamide
• Synonyms: (2S)-N-[(R)-7'-(2-chlorophenyl)-6'-(4-chlorophenyl)-3',4'-dihydrospiro[cyclohexane-1,2'-pyrano[2,3-b]pyridin]-4'-yl]-2-hydroxypropanamide
• CAS NO: 1044584-17-9
• Molecular Weight: 511.448
• Mol File: 1044584-17-9.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: (2S)-N-[(R)-7'-(2-chlorophenyl)-6'-(4-chlorophenyl)-3',4'-dihydrospiro[cyclohexane-1,2'-pyrano[2,3-b]pyridin]-4'-yl]-2-hydroxypropanamide(CAS DataBase Reference)
• NIST Chemistry Reference: (2S)-N-[(R)-7'-(2-chlorophenyl)-6'-(4-chlorophenyl)-3',4'-dihydrospiro[cyclohexane-1,2'-pyrano[2,3-b]pyridin]-4'-yl]-2-hydroxypropanamide(1044584-17-9)
• EPA Substance Registry System: (2S)-N-[(R)-7'-(2-chlorophenyl)-6'-(4-chlorophenyl)-3',4'-dihydrospiro[cyclohexane-1,2'-pyrano[2,3-b]pyridin]-4'-yl]-2-hydroxypropanamide(1044584-17-9)

Safety Data

• Hazardous Substances Data: 1044584-17-9(Hazardous Substances Data)

Upstream product

• 1044583-46-1 7'-(2-chlorophenyl)-6'-(4-chlorophenyl)spiro[cyclohexane-1,2'-pyrano[2,3-b]pyridin]-4'(3'H)-one oxime 
• 79-33-4 L-Lactic acid 
• 1044583-52-9 7'-(2-chlorophenyl)-6'-(4-chlorophenyl)-3',4'-dihydrospiro[cyclohexane-1,2'-pyrano[2,3-b]pyridin]-4'-amine 
• 867-56-1 sodium L-lactate 

Relevant articles and documents

Dihydro-pyrano[2,3-b]pyridines and tetrahydro-1,8-naphthyridines as CB1 receptor inverse agonists: Synthesis, SAR and biological evaluation

Synthesis and structure-activity relationships of cannabinoid-1 receptor (CB1R) inverse agonists based on dihydro-pyrano[2,3-b] pyridine and tetrahydro-1,8-naphtyridine scaffolds are presented. Rat food intake and pharmacokinetic evaluation of 13g, 13i, 1

SUBSTITUTED PYRANO [2, 3 - B] PYRIDINE DERIVATIVES AS CANNABINOID -1 RECEPTOR MODULATORS

Novel compounds of the structural formula (I) are antagonists and/or inverse agonists of the Cannabinoid-1 (CB1) receptor and are useful in the treatment, prevention and suppression of diseases mediated by the CB1 receptor. The compounds of the present in